Hybio Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 2, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Market Capitalization	16,040	11,385	11,994	15,527	11,138	5,917
Market Cap Growth	30.55%	-5.08%	-22.75%	39.41%	88.22%	14.66%
Enterprise Value	17,846	13,122	13,710	17,024	12,784	7,126
Last Close Price	18.16	12.89	13.58	17.58	12.61	6.65
PE Ratio	-	-	-	-	361.52	-
Forward PE	-	9.21	9.21	9.21	9.21	9.21
PS Ratio	17.86	19.29	27.80	22.05	15.13	8.20
PB Ratio	24.08	19.07	15.31	11.97	6.76	3.53
P/TBV Ratio	42.69	39.92	22.37	15.44	8.43	4.48
P/FCF Ratio	124.45	232.96	-	-	-	-
P/OCF Ratio	46.18	69.12	-	982.28	71.02	123.30
PEG Ratio	-	0.73	0.73	0.73	0.73	0.73
EV/Sales Ratio	19.87	22.23	31.78	24.17	17.37	9.87
EV/EBITDA Ratio	69.54	115.59	-	-	-	-
EV/EBIT Ratio	159.34	-	-	-	-	-
EV/FCF Ratio	138.46	268.51	-	-	-	-
Debt / Equity Ratio	2.90	3.01	2.59	1.39	1.09	1.16
Debt / EBITDA Ratio	7.52	15.72	-	-	-	-
Debt / FCF Ratio	14.97	36.79	-	-	-	-
Asset Turnover	0.29	0.19	0.13	0.19	0.19	0.17
Inventory Turnover	1.50	1.44	1.52	1.12	1.58	0.91
Quick Ratio	0.16	0.14	0.36	0.52	1.28	0.74
Current Ratio	0.37	0.33	0.48	0.71	1.55	0.95
Return on Equity (ROE)	-10.67%	-26.10%	-49.56%	-25.30%	1.71%	-31.16%
Return on Assets (ROA)	2.23%	-0.64%	-6.74%	-3.03%	-4.26%	-7.79%
Return on Invested Capital (ROIC)	4.59%	-1.36%	-14.00%	-6.44%	-7.61%	-16.48%
Return on Capital Employed (ROCE)	6.80%	-2.00%	-20.00%	-7.40%	-8.50%	-18.70%
Earnings Yield	-0.42%	-1.52%	-4.28%	-2.39%	0.28%	-10.30%
FCF Yield	0.80%	0.43%	-0.71%	-1.12%	-0.38%	-3.31%
Payout Ratio	-	-	-	-	375.37%	-
Buyback Yield / Dilution	-2.67%	2.00%	-0.42%	14.09%	-11.21%	-0.19%
Total Shareholder Return	-2.67%	2.00%	-0.42%	14.09%	-11.21%	-0.19%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.